SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes
Journal of Vascular Surgery · 2025-06 · 81 (6) · e140-e142
DOI: 10.1016/j.jvs.2025.03.279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2025-06. Verfasst von Uma D. Alappan und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alappan, U. D., Chetty, A. K., Carter, W., Wells, N., Alameddine, D., Inzucchi, S., Guzman, R. J., & Chaar, C. I. O. (2025). SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes. Journal of Vascular Surgery, 81(6), e140-e142. https://doi.org/10.1016/j.jvs.2025.03.279
Vancouver
Alappan UD, Chetty AK, Carter W, Wells N, Alameddine D, Inzucchi S, et al. SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes. Journal of Vascular Surgery. 2025;81(6):e140-e142. doi:10.1016/j.jvs.2025.03.279
BibTeX
@article{Alappan2025,
author = {Alappan, Uma D. and Chetty, Ashwin K. and Carter, Warren and Wells, Nicholas and Alameddine, Dana and Inzucchi, Silvio and Guzman, Raul J. and Chaar, Cassius Iyad Ochoa},
title = {SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes},
journal = {Journal of Vascular Surgery},
year = {2025},
volume = {81},
number = {6},
pages = {e140--e142},
doi = {10.1016/j.jvs.2025.03.279}
}
EUVIMED